J Hepatol

ISSN	1600-0641
ISSN-L	-
IUID	1510a2b3a2c446768807d69fe997ba16
Modified	2022-12-05 15:00:14
Created	2022-12-05 15:00:14

Year 2022

PubMed DOI Crossref

Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.

Patel VC, Lee S, McPhail MJW, ..., Shoaie S, Shawcross DL

J Hepatol 76 (2) 332-342 [2022-02-00; online 2021-09-24]

Saeed Shoaie SciLifeLab Fellow

SciLifeLab Data Centre

Publications 9.5.1